UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027566
Receipt number R000031606
Scientific Title Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material
Date of disclosure of the study information 2017/05/31
Last modified on 2021/11/18 02:02:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material

Acronym

Sinus floor augmentation by HAp/Col

Scientific Title

Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material

Scientific Title:Acronym

Sinus floor augmentation by HAp/Col

Region

Japan


Condition

Condition

missing tooth

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess bone negeneration for sinus flooraugmentation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ISQ 6 months after implantation.

Key secondary outcomes

1. new bone formation.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patient who needs sinus floor augmentation for dental implantation.

Key exclusion criteria

1. uncontrolled DM
2. severe renal and hepatic disorders.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Seigo
Middle name
Last name Ohba

Organization

Nagasaki University

Division name

Division of Regenerative Oral Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7704

Email

sohba@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Seigo
Middle name
Last name Ohba

Organization

Nagasaki University

Division name

Division of Regenerative Oral Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki

TEL

095-819-7704

Homepage URL


Email

sohba@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University

Address

1-7-1 Sakamoto, Nagasaki

Tel

095-819-7704

Email

sohba@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 31 Day


Related information

URL releasing protocol

https://www.jstage.jst.go.jp/article/josnusd/63/3/63_21-0163/_article/-char/ja/

Publication of results

Unpublished


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/josnusd/63/3/63_21-0163/_article/-char/ja/

Number of participants that the trial has enrolled

11

Results

This material induces the new bone formation in the maxillary sinus. On the other hand, some implants could not acquire the osseointegration when the original bone volume was insufficient.

Results date posted

2021 Year 11 Month 18 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Nineteen implants were placed into 14 maxillary sinuses.

Participant flow

Two implants were placed in 2 maxillary sinuses via the crestal approach, and 17 implants (OsseoSpeed; 10 implants, Finesia; 1 implant, Straumann; 6 implants) were placed in 12 maxillary sinuses via the lateral approach.

Adverse events

Three implants were lost.

Outcome measures

The alveolar bone height and cortical bone thickness of the alveo- lar bone ridge (cortical bone thickness) at the implant placement positions were measured on preoperative CBCT (3D Accuitomo F17D, Morita, Kyoto, Japan) images. Insertion torque and ISQ were also measured.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 05 Day

Date of IRB

2015 Year 11 Month 05 Day

Anticipated trial start date

2015 Year 11 Month 05 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

presentation at the annual meeting of Japanese association of oral implanvology in 23018.


Stop the exam.


Management information

Registered date

2017 Year 05 Month 31 Day

Last modified on

2021 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031606


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name